HOW I DO IT

• M inverted V glansplasty: an update on technique and outcomes 30 years later

  Burns Amy, Harrington Stephen, Boltz Suzanne, Decter M. Ross Department of Urology, The Pennsylvania State University, College of Medicine, Hershey, Pennsylvania, USA

  ---

  Distal hypospadias is a common congenital urology anomaly for which numerous corrective procedures have been described. Over the last 40 years, the gold-standard operative technique for distal hypospadias has switched from the meatal advancement and glanuloplasty (MAGPI) procedure to the tubularized incised plate (TIP) urethroplasty. A modification to the MAGPI procedure, first described 30 years ago, is the M inverted V (MIV) glansplasty, which improved upon the MAGPI procedure to reduce instances of meatal retraction. The MIV glansplasty is unique compared to many commonly used procedures as it does not require a formal urethroplasty or incorporation of a dartos flap, and it does not always necessitate as extensive mobilization of the glans wings. We describe our updated technique and outcomes of the MIV glansplasty and delineate situations where the MIV is best employed.

  Keywords: urethra, surgery, hypospadias, penis, complication,

  Oct 2022 (Vol. 29, Issue 5 , Page 11335)
  PDF (1.54MB)Free
• DNA analysis for prostate specimen verification: How I Do It

  Salib Andrew, Mark Ryan J., MD Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA

  ---

  Prostate cancer is the most common malignancy affecting men. Prostate biopsy remains the key clinical tool for selecting appropriate treatment options. The process of specimen collection and diagnosis is multistep and vulnerable to human error along every stage. Specimen provenance testing (SPT) aims to provide certainty that biopsy results can be trusted when recommending life changing treatments and has emerged as a necessary tool in medicine to counteract human error and specimen contamination. In this study we report our practice's experience using the Know Error test to verify prostate biopsy specimens. In this study, we retrospectively reviewed the results of a specific SPT known as Know Error which is used in our institution for specimen verification during prostate biopsy. Over a period of 16 months, we identified 445 patients with a total of 921 specimens. The percentage of patients who had 1, 2 or 3 specimens analyzed was 29%, 38%, and 30%, respectively. Our cohort's rate of specimen verification was 92.8% with a 2.8% contamination rate. The pathology reports for 445 patients were then examined to determine Gleason Grade Group (GG) showing 180 GG1 and 148 GG2 patients. Cross reference of pathology reports and Know Error reports showed 8 GG1 and 9 GG2 patients had contaminated biopsy specimens. Specimen provenance complications such as contamination can negatively impact patient counselling and treatment modalities leading to unnecessary intervention and detrimental patient outcomes.

  Keywords: DNA analysis, specimen contamination, prostate biopsies, specimen provenance complications,

  Feb 2021 (Vol. 28, Issue 1 , Page 10568)
  PDF (618.8KB)Free
• How I Do It: Techniques to avoid complications in transvaginal mesh surgery

  Faber Ken, Fromer Debra, MD Department of Urology, Hackensack University Medical Group, Hackensack, New Jersey, USA

  ---

  This article details recommendations on minimizing complications in pelvic floor reconstruction using mesh. It is designed to incorporate real world experience from an expert urologist in female pelvic floor reconstruction with medical literature and prevailing theories.

  Keywords: pelvic organ prolapse, transvaginal mesh, mesh complications,

  Jun 2015 (Vol. 22, Issue 3 , Page 7844)
  Full Text   |  PDF (47.8KB)Free